nalbuphine HCl ER tablets 90 mg BID

Drug identity checked against registry records

Also recorded as nalbuphine ER

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Study of Nalbuphine HCl ER Tablets in Patients With Prurigo NodularisNCT02174419Trevi TherapeuticsPhase 2, Phase 3Completed2016-08Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.